JP MORGAN SERIES TRUST
NSAR-B, EX-27, 2000-12-28
Previous: JP MORGAN SERIES TRUST, NSAR-B, 2000-12-28
Next: JP MORGAN SERIES TRUST, NSAR-B, EX-27, 2000-12-28


WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE> 6
<LEGEND>
This schedule contains summary financial data extracted from the annual report
dated October 31, 2000 for the J.P. Morgan Global Healthcare Fund - Select
Shares and is qualified in its entirety by reference to such annual report.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-END>                               OCT-31-2000
<INVESTMENTS-AT-COST>                            34570
<INVESTMENTS-AT-VALUE>                           34985
<RECEIVABLES>                                      179
<ASSETS-OTHER>                                    1090
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                   36254
<PAYABLE-FOR-SECURITIES>                           187
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                          258
<TOTAL-LIABILITIES>                                445
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                         35467
<SHARES-COMMON-STOCK>                             2370
<SHARES-COMMON-PRIOR>                                0
<ACCUMULATED-NII-CURRENT>                           69
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                              0
<OVERDISTRIBUTION-GAINS>                           127
<ACCUM-APPREC-OR-DEPREC>                           400
<NET-ASSETS>                                     35808
<DIVIDEND-INCOME>                                   13
<INTEREST-INCOME>                                    0
<OTHER-INCOME>                                       0
<EXPENSES-NET>                                      41
<NET-INVESTMENT-INCOME>                           (28)
<REALIZED-GAINS-CURRENT>                          (78)
<APPREC-INCREASE-CURRENT>                          400
<NET-CHANGE-FROM-OPS>                              294
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                            0
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                          35669
<NUMBER-OF-SHARES-REDEEMED>                        154
<SHARES-REINVESTED>                                  0
<NET-CHANGE-IN-ASSETS>                           35809
<ACCUMULATED-NII-PRIOR>                              0
<ACCUMULATED-GAINS-PRIOR>                            0
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                               35
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                    126
<AVERAGE-NET-ASSETS>                             34036
<PER-SHARE-NAV-BEGIN>                               15
<PER-SHARE-NII>                                    .03
<PER-SHARE-GAIN-APPREC>                            .08
<PER-SHARE-DIVIDEND>                                 0
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              15.11
<EXPENSE-RATIO>                                   1.50



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission